Mitigating Risk and Improving Outcomes: Next-Generation Radiofrequency Ablation Devices Propel the US Healthcare Sector Forward
The application of Radiofrequency Ablation (RFA) devices in surgical oncology represents the single largest revenue stream within the US market, fundamentally altering the way physicians approach the treatment of solid tumors. RFA offers a compelling alternative or adjunct to traditional surgery, especially for high-risk patients or those with smaller, localized tumors in hard-to-reach organs....
0 Commenti 0 condivisioni 33 Views 0 Anteprima